BSEInsider Trading / SAST1d ago · 19 Aug 2026, 11:17 am
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sudhir Sethi
Beryl Drugs Ltd · 524606
✦ AI SummaryRelated Party
Beryl Drugs Ltd has received a disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, related to Sudhir Sethi's acquisition of shares.
Analysis Scores
Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk2/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Beryl Drugs Ltd - 524606 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011